Onconova Therapeutics, Inc.

NASDAQ:ONTX

0.89 (USD) • At close April 2, 2024
Bedrijfsnaam Onconova Therapeutics, Inc.
Symbool ONTX
Munteenheid USD
Prijs 0.995
Beurswaarde 20,904,684
Dividendpercentage 0%
52-weken bereik 0.551 - 1.45
Industrie Biotechnology
Sector Healthcare
CEO Dr. Steven M. Fruchtman M.D.
Website https://www.onconova.com

An error occurred while fetching data.

Over Onconova Therapeutics, Inc.

Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a single agent or in

Vergelijkbare Aandelen

Landos Biopharma, Inc. logo

Landos Biopharma, Inc.

LABP

22.93 USD

Abeona Therapeutics Inc. logo

Abeona Therapeutics Inc.

ABEO

6.57 USD

Sio Gene Therapies Inc. logo

Sio Gene Therapies Inc.

SIOX

0.415 USD

Ekso Bionics Holdings, Inc. logo

Ekso Bionics Holdings, Inc.

EKSO

0.96 USD

Aytu BioPharma, Inc. logo

Aytu BioPharma, Inc.

AYTU

1.995 USD

Cellectar Biosciences, Inc. logo

Cellectar Biosciences, Inc.

CLRB

2.05 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)